SCLC-I had previously been characterised by low expression of ASCL1, but the authors now show that among these two subsets, ASCL1 is high in only one of them, suggesting that the SCLC classification should be expanded and better defined, especially considering the immune heterogeneity within the subsets [28]. Here, ASCL1 is linked to small cell lung carcinoma.